Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1956 Sep;11(3):289–294. doi: 10.1111/j.1476-5381.1956.tb01068.x

The effects of 5-hydroxytryptamine and its antagonists on tidal air

H Konzett
PMCID: PMC1509610  PMID: 13364203

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARER G. W., NUSSER E. The part played by bronchial muscles in pulmonary reflexes. Br J Pharmacol Chemother. 1953 Sep;8(3):315–320. doi: 10.1111/j.1476-5381.1953.tb00800.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BHATTACHARYA B. K. A pharmacological study on the effect of 5-hydroxytryptamine and its antagonists on the bronchial musculature. Arch Int Pharmacodyn Ther. 1955 Oct 1;103(2-3):357–369. [PubMed] [Google Scholar]
  3. CERLETTI A., KONZETT H. Spezifische Hemmung von 5-Oxytryptamin-Effekten durch Lysergsäurediäthylamid und ähnliche Körper. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956;228(1-2):146–148. [PubMed] [Google Scholar]
  4. CERLETTI A., ROTHLIN E. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature. 1955 Oct 22;176(4486):785–786. doi: 10.1038/176785a0. [DOI] [PubMed] [Google Scholar]
  5. COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
  6. ERSPAMER V. Pharmacology of indole-alkylamines. Pharmacol Rev. 1954 Dec;6(4):425–487. [PubMed] [Google Scholar]
  7. FREYBURGER W. A., GRAHAM B. E., RAPPORT M. M., SEAY P. H., GOVIER W. M., SWOAP O. F., VANDER BROOK M. J. The pharmacology of 5-hydroxytryptamine (serotonin). J Pharmacol Exp Ther. 1952 May;105(1):80–86. [PubMed] [Google Scholar]
  8. GADDUM J. H., HEBB C. O., SILVER A., SWAN A. A. 5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs. Q J Exp Physiol Cogn Med Sci. 1953;38(4):255–262. doi: 10.1113/expphysiol.1953.sp001037. [DOI] [PubMed] [Google Scholar]
  9. GINZEL K. H., KOTTEGODA S. R. A study of the vascular actions of 5-hydroxytryptamine, tryptamine, adrenaline and noradrenaline. Q J Exp Physiol Cogn Med Sci. 1953;38(4):225–231. doi: 10.1113/expphysiol.1953.sp001033. [DOI] [PubMed] [Google Scholar]
  10. HERXHEIMER H. The bronchial reaction of guinea-pigs to 5-hydroxytryptamine (serotonin). J Physiol. 1953 Jun 29;120(4):65P–66P. [PubMed] [Google Scholar]
  11. KOTTEGODA S. R., MOTT J. C. Cardiovascular and respiratory actions of 5-hydroxytryptamine in the cat. Br J Pharmacol Chemother. 1955 Mar;10(1):66–72. doi: 10.1111/j.1476-5381.1955.tb00062.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. REID G., RAND M. Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin). Nature. 1952 May 10;169(4306):801–802. doi: 10.1038/169801a0. [DOI] [PubMed] [Google Scholar]
  13. ROTHLIN E., CERLETTI A. Pharmacologic studies on a new antihistamine and its combination with calcium. Ann Allergy. 1955 Jan-Feb;13(1):80–89. [PubMed] [Google Scholar]
  14. SINHA Y. K., WEST G. B. The antagonism between local anaesthetic drugs and 5-hydroxytryptamine. J Pharm Pharmacol. 1953 Jun;5(6):370–374. doi: 10.1111/j.2042-7158.1953.tb13998.x. [DOI] [PubMed] [Google Scholar]
  15. STOLL A., ROTHLIN E., RUTSCHMANN J., SCHALCH W. R. Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD 25) in the animal body. Experientia. 1955 Oct 15;11(10):396–397. doi: 10.1007/BF02158503. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES